Adjuvant Therapies for Primary Cardiac Malignancies

We gratefully acknowledge the support of Henry and Barbara Bank


Watch the welcome message provided by Program Director Dr. RJ Cusimano.


To determine the advantages and shortcomings of different adjuvant therapies for Primary Cardiac Malignancy.


By the end of the conference, the participant will be able to :

  • Describe the 3D rendering of CT scans can help in the evaluation of cardiac tumour
  • Interpret the data surrounding neo adjuvant and adjuvant therapies for cardiac malignancies
  • Discuss the advantages and challenges facing a national and international database for cardiac tumour

Endorsed by:

The Society of Thoracic Surgeons
Cancer Care Ontario
Peter Munk Cardiac Centre at UHN